161 related articles for article (PubMed ID: 30769948)
1. Immunomodulatory Effects of (24R)-Pseudo-Ginsenoside HQ and (24S)-Pseudo-Ginsenoside HQ on Cyclophosphamide-Induced Immunosuppression and Their Anti-Tumor Effects Study.
Qi Z; Chen L; Li Z; Shao Z; Qi Y; Gao K; Liu S; Sun Y; Li P; Liu J
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769948
[TBL] [Abstract][Full Text] [Related]
2. Study on Antidepressant Activity of Pseudo-Ginsenoside HQ on Depression-Like Behavior in Mice.
Chen LX; Qi Z; Shao ZJ; Li SS; Qi YL; Gao K; Liu SX; Li Z; Sun YS; Li PY
Molecules; 2019 Mar; 24(5):. PubMed ID: 30823679
[TBL] [Abstract][Full Text] [Related]
3. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.
Zhu H; He YS; Ma J; Zhou J; Kong M; Wu CY; Mao Q; Lin G; Li SL
J Ethnopharmacol; 2021 Jan; 265():113271. PubMed ID: 32853742
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice.
Liu X; Zhang Z; Liu J; Wang Y; Zhou Q; Wang S; Wang X
Int Immunopharmacol; 2019 Jul; 72():98-111. PubMed ID: 30974284
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
6. Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice.
Wu R; Ru Q; Chen L; Ma B; Li C
J Food Sci; 2014 Jul; 79(7):H1430-5. PubMed ID: 25041540
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma.
Chang HH; Hsieh KY; Yeh CH; Tu YP; Sheu F
Int Immunopharmacol; 2010 Feb; 10(2):239-46. PubMed ID: 19909827
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory effects of ginsenoside derivative Rh2-O on splenic lymphocytes in H22 tumor-bearing mice is partially mediated by TLR4.
Wu HC; Hu QR; Luo T; Wei WC; Wu HJ; Li J; Zheng LF; Xu QY; Deng ZY; Chen F
Int Immunopharmacol; 2021 Dec; 101(Pt B):108316. PubMed ID: 34768129
[TBL] [Abstract][Full Text] [Related]
10. Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells.
Zhang F; Xu H; Xia R; Yu P; Li Y; Yu X; Sui D
Recent Pat Anticancer Drug Discov; 2021; 16(4):521-532. PubMed ID: 34109916
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.
Jiang JW; Chen XM; Chen XH; Zheng SS
World J Gastroenterol; 2011 Aug; 17(31):3605-13. PubMed ID: 21987607
[TBL] [Abstract][Full Text] [Related]
12. Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice.
Liu YH; Qin HY; Zhong YY; Li S; Wang HJ; Wang H; Chen LL; Tang X; Li YL; Qian ZY; Li HY; Zhang L; Chen T
BMC Cancer; 2021 Jan; 21(1):37. PubMed ID: 33413214
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
14. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis.
Li W; Tian YH; Liu Y; Wang Z; Tang S; Zhang J; Wang YP
J Toxicol Sci; 2016; 41(3):417-28. PubMed ID: 27193733
[TBL] [Abstract][Full Text] [Related]
15. Octyl ester of ginsenoside compound K as novel anti-hepatoma compound: Synthesis and evaluation on murine H22 cells in vitro and in vivo.
Hou J; Xue J; Zhao X; Wang Z; Li W; Li X; Zheng Y
Chem Biol Drug Des; 2018 Apr; 91(4):951-956. PubMed ID: 29193880
[TBL] [Abstract][Full Text] [Related]
16. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Chen W; Qiu Y
Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
Kang XM; Zhang QY; Tong DD; Zhao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
[TBL] [Abstract][Full Text] [Related]
19. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
Lu M; Fei Z; Zhang G
Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
